Effect of Controlled Adverse Environment (CAE) on Tear Film Stability
NCT01547936 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33
Last updated 2012-03-08
Summary
The purpose of this study is to evaluate the effect of the controlled adverse environment (CAE) on Mean Break-Up Area in subjects diagnosed with Dry Eye Syndrome.
Conditions
- Keratoconjunctivitis Sicca
Sponsors & Collaborators
-
ORA, Inc.
lead INDUSTRY
Principal Investigators
-
Tarek Shazly, MD · Ophthalmic society of Egypt, Egyptian Glaucoma Society, American Acadamy of Ophthalmology, American Glaucoma Society, The association for research in vision and ophthalmology, international society of refractive surgery, Pan Arab Glaucoma Society
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-02-29
- Primary Completion
- 2012-02-29
- Completion
- 2012-02-29
Countries
- United States
Study Locations
More Related Trials
-
An Observational Study to Assess Optive MEGA-3 (OM3) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)
NCT06439394 ·Status: COMPLETED
-
Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye
NCT02326090 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Clinical Study Assessing the Effects of Tetracycline Antibiotic on Tear Film and Tear Lipid Composition Within a Population of Patients Diagnosed With Blepharitis and Dry Eye Disease
NCT00355459 ·Status: WITHDRAWN ·Phase: NA
-
Tear Film Break-up Time After Instillation of Artificial Tears
NCT00681265 ·Status: COMPLETED ·Phase: NA
-
A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome
NCT03162783 ·Status: COMPLETED ·Phase: PHASE2
-
Tear Film Break-Up Time Evaluation of FID 114657
NCT01023464 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Evaluation of the Tear Film
NCT00761917 ·Status: COMPLETED
-
Evaluation of the Effect of Repeated Usage on the Tear Film Characteristics of an Investigational Eye Drop in Dry Eye Sufferers
NCT01339936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)
NCT02121301 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease
NCT01733992 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of the TearCare System in Adults With Dry Eye Disease
NCT03006978 ·Status: COMPLETED ·Phase: NA
-
Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
NCT03925727 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.
NCT02553772 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye
NCT01257607 ·Status: COMPLETED ·Phase: PHASE2
-
0.3% Sodium Hyaluronate Eye Drop to Prevent Recurrent Corneal Epithelium Exfoliation
NCT03000556 ·Status: UNKNOWN ·Phase: PHASE3
-
A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model
NCT00814944 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points
NCT00345241 ·Status: COMPLETED ·Phase: NA
-
Management of the Ocular Surface With Preservative-Free Lubricants in Patients With Dry Eye
NCT06162442 ·Status: RECRUITING
-
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
NCT00565669 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
NCT03088605 ·Status: COMPLETED ·Phase: PHASE2
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Blue Wavelength in Managing Dry Eye
NCT04965974 ·Status: UNKNOWN ·Phase: NA
-
An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake
NCT04280653 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.
NCT04362670 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye
NCT02634853 ·Status: COMPLETED ·Phase: PHASE3